ArticleFrontiers in cell and developmental biology2026
Early proteomic signatures of Alzheimer's disease in the retina and brain of 3xTg-AD mice.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Visual dysfunction and retinal structural changes can occur early in Alzheimer's disease (AD), but the molecular basis of these early alterations remains unclear. Methods: We performed quantitative proteomic profiling of the retina and brain from 4-week-old triple-transgenic AD (3xTg-AD) mice carrying human PS1M Results: Retinal morphology was normal in 4-week-old 3xTg-AD. Proteomic analysis identified 92 significantly altered proteins in the retina and 130 in the brain, with eight proteins overlapping between tissues. These overlapping proteins included three hemoglobin subunits and five proteins involved in protein homeostasis and vesicular transport. The retinal proteome was characterized by reduced vision-related proteins, altered small-molecule transporters, and decreased levels of proteins involved in mitochondrial energetics. In the brain, prominent changes were observed in mitochondrial proteins, including respiratory chain components and mitochondrial ribosomal subunits, as well as proteins linked to autophagy and synaptic vesicle pathways. Discussion: These findings identify early, common and tissue-specific proteomic changes in the retina and brain of 3xTg-AD mice prior to detectable retinal structure abnormalities. The data indicate early changes in proteins related to mitochondrial function and intracellular transport and support the use of retina as an accessible tissue for detecting preclinical AD pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.